Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

Friedeberg brings more than 16 years of experience in economic development, having previously held leadership roles with the Michigan Economic Development Corporation. He currently serves as president ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

Another notable valuation metric for GMED is its P/B ratio of 2.38. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For ...

GMed, a Modernizing Medicine Co., will soon become Modernizing Medicine Gastroenterology with a number of its offerings also taking on new identities later this year. Here's what you should know: 1.

Globus Medical, Inc. (GMED) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home page ...

Investors in Globus Medical Inc (Symbol: GMED) saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...